A First-In-Human Phase I Study Of The Axl Inhibitor Ds-1205c In Combination With Gefitinib In Subjects With Egfr-Mutant NsclcM. Nishio, I. Okamoto,H. Murakami,H. Horinouchi, R. Toyozawa,M. Takeda,M. Uno, N. Crawford,T. Jimbo,M. Ishigami, G. Takayama, S. Nakayama,S. Ohwada, E. Slosberg, K. GotoAnnals of Oncology（2020）引用 5|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
